Aldaas, Omar M.
Darden, Douglas
Mylavarapu, Praneet S.
Han, Frederick T.
Hoffmayer, Kurt S.
Krummen, David
Ho, Gordon
Raissi, Farshad
Feld, Gregory K.
Hsu, Jonathan C. http://orcid.org/0000-0002-1523-573X
Article History
Received: 30 September 2022
Accepted: 3 December 2022
First Online: 12 December 2022
Declarations
:
: Dr. Hsu reports receiving honoraria from Medtronic, Abbott, Boston Scientific, Biotronik, Janssen Pharmaceuticals, Bristol-Myers Squibb, Pfizer, Sanofi, Zoll Medical, Hillrom, iRhythm, Acutus Medical, and Biosense-Webster; equity interest in Vektor Medical; research grants from Biotronik and Biosense-Webster; and research funding support from the Marouf Family and the Butler and Gratt family. Dr. Ho reports receiving a research grant from Abbott, equity in Vektor Medical, and fellowship support from Medtronic, Abbott, Boston Scientific, and Biotronik. Dr. Feld reports receiving a fellowship stipend support from Abbott, Medtronic, Boston Scientific, and Biotronik, and has equity interest in Vektor Medical.
: This study used data collected as part of the University of California (UC) San Diego AF Ablation Registry and approved by the UC San Diego Institutional Review Board.
: N/A (observational, retrospective study).